A Prospective Randomized, Double-Blind Comparison of LY900014 to Humalog with an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents with Type 1 Diabetes PRONTO-Peds
-
- STATUS
- Recruiting
Summary
The study medication for this research study is called LY900014. It is a type of mealtime insulin. The main reason for you to take part in this study is not to treat you for your diabetes but to help in answering the following research questions:
•Does LY900014 help to lower blood glucose levels in patients with type 1 diabetes?
•How LY900014 controls blood glucose levels compared to Humalog.
Details
| Condition | Type 1 Diabetes |
|---|---|
| Age | 1years - 18years |
| Clinical Study Identifier | TX10572 |
| Last Modified on | 19 February 2024 |
Eligibility
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.